Timeline

Pierre Goossens

Permanent Researcher

30 Mar 2023

publication

Early expression of capsule during Bacillus anthracis germination.

23 Sep 2016

news

Seminar of the Infection & Epidemiology Department

26 May 2015

publication

Micropatterned Macrophage Analysis Reveals Global Cytoskeleton Constraints Induced by Bacillus anthracis Edema Toxin

11 May 2015

team

Yersinia

01 Apr 2015

publication

Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis

01 Nov 2012

publication

Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection

12 Jan 2012

publication

Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins

01 Jun 2011

publication

Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax

06 Feb 2010

publication

Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host

04 Dec 2009

publication

Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation

01 Nov 2009

publication

Encapsulated Bacillus anthracis interacts closely with liver endothelium

07 Aug 2009

publication

Animal models of human anthrax: the Quest for the Holy Grail

03 Apr 2009

publication

Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification

13 Aug 2008

publication

Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting

01 Dec 2007

publication

Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages

16 Jul 2007

publication

Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice

01 Jun 2007

publication

Primary involvement of pharynx and peyer’s patch in inhalational and intestinal anthrax

01 Mar 2007

publication

Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis

01 Feb 2007

publication

Of spore opsonization and passive protection against anthrax

18 Sep 2006

publication

Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores

01 Aug 2005

publication

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin

01 Jul 2004

publication

High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin

01 Mar 2003

publication

Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope

21 Jun 2002

publication

Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection

A little guide for advanced search:

Early expression of capsule during Bacillus anthracis germination.

Seminar of the Infection & Epidemiology Department

Micropatterned Macrophage Analysis Reveals Global Cytoskeleton Constraints Induced by Bacillus anthracis Edema Toxin

Yersinia

Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis

Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection

Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins

Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax

Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host

Anthrax lethal toxin down-regulates type-IIA secreted phospholipase A(2) expression through MAPK/NF-kappaB inactivation

Encapsulated Bacillus anthracis interacts closely with liver endothelium

Animal models of human anthrax: the Quest for the Holy Grail

Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification

Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting

Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages

Noncapsulated toxinogenic Bacillus anthracis presents a specific growth and dissemination pattern in naive and protective antigen-immune mice

Primary involvement of pharynx and peyer’s patch in inhalational and intestinal anthrax

Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis

Of spore opsonization and passive protection against anthrax

Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin

High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin

Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope

Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection